Is Hidradenitis Suppurativa Spreadable? Here’s What You Should Know

Is Hidradenitis Suppurativa Spreadable? Here’s What You Should Know

Introduction

Hidradenitis Suppurativa (HS) is a chronic inflammatory skin condition that causes painful lumps, abscesses, and sinus tracts, primarily in areas with sweat glands like the armpits, groin, and buttocks (Sabin et al., 2020). One common misconception about HS is whether it is spreadable or contagious. While the symptoms may resemble infections, HS is not spread from person to person (Alikhan et al., 2010). Understanding its nature, causes, and management can help dispel myths and promote effective treatment.

At EliteAyurveda, we provide a holistic approach to managing HS, focusing on its root causes and overall well-being.

Is Hidradenitis Suppurativa Spreadable

Is HS Contagious?

The simple answer is no, Hidradenitis Suppurativa is not contagious (Ingram et al., 2016). It cannot be spread through:

1. Physical contact with an affected person.
2. Sharing personal items like towels or clothing.
3. Sexual activity or other intimate interactions.

HS is not caused by bacteria or viruses, making it fundamentally different from contagious skin conditions like impetigo or fungal infections (Sabin et al., 2020).

What Causes Hidradenitis Suppurativa?

HS is an autoimmune condition, meaning the body’s immune system mistakenly attacks its own tissues. The exact cause is unknown, but it is linked to the following factors:

1. Hair Follicle Blockage

• In HS, hair follicles become clogged, leading to inflammation and abscess formation (Jemec & Heidenheim, 1996).

2. Overactive Immune Response

• The immune system’s excessive response causes chronic inflammation and tissue damage (Giamarellos-Bourboulis et al., 2016).

3. Genetic Predisposition

• HS often runs in families, suggesting a hereditary component (Fimmel & Zouboulis, 2020).

4. Hormonal Fluctuations

• Hormones play a significant role, as HS often worsens during puberty, menstrual cycles, and pregnancy (van der Zee & Prens, 2011).

5. Lifestyle and Environmental Factors

• Smoking, obesity, and stress are known to aggravate HS symptoms (Egeberg et al., 2016).

Common Misconceptions About HS

1. “HS is an Infection.”

While the lesions and abscesses of HS can become secondarily infected, the condition itself is not caused by infection. The inflammation originates from blocked hair follicles and immune system dysfunction (Sabin et al., 2020).

2. “You Can Catch HS from Someone Else.”

Since HS is not caused by a pathogen, it cannot be transmitted through contact or shared items (Alikhan et al., 2010).

3. “Poor Hygiene Causes HS.”

HS is not related to cleanliness. It is a medical condition with underlying genetic, hormonal, and immune factors (Gulliver et al., 2016).

Why the Misconception About Contagion Exists

The visible symptoms of HS—such as abscesses, pus, and scarring—can resemble contagious skin conditions. This leads to stigma and misinformation, often causing emotional distress for those living with HS (Machado et al., 2019). Educating patients and the public is essential to combating this stigma.

How HS Manifests

1. Early Stages

• Small, tender lumps resembling boils.
• These may heal temporarily but often recur in the same area (Ingram et al., 2016).

2. Progression

• Abscesses deepen and form sinus tracts (tunnels under the skin).
• Scarring and pigmentation changes occur over time (Sabin et al., 2020).

3. Chronic Stage

• Severe, persistent inflammation and interconnected sinus tracts.
• This can lead to restricted movement and emotional distress (Gulliver et al., 2016).

Ayurvedic Perspective on Hidradenitis Suppurativa

In Ayurveda, HS is viewed as an imbalance in the Pitta (fire) and Kapha (water and earth) doshas, combined with toxin buildup (Ama) in the body (Lad, 2002). These imbalances manifest as chronic inflammation, blockages, and abscess formation.

Key Ayurvedic Insights

• Pitta Aggravation: Causes heat and inflammation, leading to redness and swelling (Frawley, 2000).
• Kapha Imbalance: Contributes to blockages and sluggish circulation, causing recurrent lumps (Pole, 2013).
• Ama (Toxins): Poor digestion and metabolic inefficiencies lead to toxin accumulation, exacerbating symptoms (Sharma et al., 2007).

Holistic Management of HS Through Ayurveda

At EliteAyurveda, we focus on addressing the root causes of HS with personalized treatment plans.

1. Detoxification (Shodhana)

• Purpose: Remove toxins from the body to reduce inflammation and prevent recurrence (Sharma et al., 2007).
• Methods: topical formulations (Phase E) and herbal formulations tailored to individual needs (Pole, 2013).

2. Personalized Herbal Medications

• Goal: Balance Pitta and Kapha doshas, strengthen immunity, and support skin healing (Lad, 2002).

3. Dietary Adjustments

• Foods to Favor: Cooling, anti-inflammatory foods like leafy greens, cucumbers, and coconut water (Frawley, 2000).
• Foods to Avoid: Spicy, oily, and processed foods that aggravate inflammation (Pole, 2013).

4. Lifestyle Modifications

• Stress Management: Incorporate yoga, meditation, and pranayama to reduce stress (Sharma et al., 2007).
• Hydration and Hygiene: Regular hydration and gentle skincare to support healing (Lad, 2002).

5. Regular Follow-Ups

• Monitoring progress and adjusting treatment as needed for long-term management.

Case Study: A Patient’s Journey with HS

Patient Profile:

• Name: Meera (Name Changed)
• Age: 29
• Symptoms: Recurrent abscesses in the groin and underarms for 5 years, with scarring and pain.
• Previous Diagnosis: Misdiagnosed as a bacterial infection and treated with antibiotics, which offered no relief.

Treatment Plan:

1. Detoxification: Weekly Ayurvedic therapies to cleanse the lymphatic system and reduce inflammation (Sharma et al., 2007).
2. Herbal Medications: Customized formulations to balance Pitta and Kapha (Lad, 2002).
3. Dietary Guidance: Anti-inflammatory and Pitta-pacifying diet (Frawley, 2000).
4. Stress Management: Daily yoga and mindfulness practices to reduce triggers (Sharma et al., 2007).

Outcome:

• 8 Weeks: Reduced frequency and severity of flare-ups.
• 6 Months: No new abscesses, with noticeable improvement in scarring and overall skin texture.

Key Takeaways

1. HS is Not Contagious: It is a chronic inflammatory condition with no infectious origin (Alikhan et al., 2010).
2. Holistic Care is Essential: Addressing root causes through Ayurveda ensures sustainable relief (Sharma et al., 2007).
3. Educate and Empower: Understanding HS helps dispel myths and reduce stigma (Machado et al., 2019).

Conclusion

Hidradenitis Suppurativa is a complex condition that requires a comprehensive approach for effective management. While it is not contagious, its impact on physical and emotional health can be profound. At EliteAyurveda, we focus on restoring balance to the body through personalized, Ayurvedic care, helping patients achieve long-term relief and improved quality of life.

Take control of your HS journey today.

📞 Contact us at +91 8884722246

🌐 Visit our website: www.eliteayurveda.com

Related-

Know More About Ayurveda Treatment for Hidradenitis Suppurativa.

GET IN TOUCH

Schedule a Visit

Contact us

References

1.Jemec GB. Clinical practice. Hidradenitis suppurativa. N Engl J Med. 2012;366(2):158–64. doi: 10.1056/NEJMcp1014163. [DOI] [PubMed] [Google Scholar]

2.Sellheyer K, Krahl D. “Hidradenitis suppurativa” is acne inversa! An appeal to (finally) abandon a misnomer. Int J Dermatol. 2005;44(7):535–40. doi: 10.1111/j.1365-4632.2004.02536.x. [DOI] [PubMed] [Google Scholar]

3.Alikhan A, Lynch PJ, Eisen DB. Hidradenitis suppurativa: a comprehensive review. J Am Acad Dermatol. 2009;60(4):539–61. doi: 10.1016/j.jaad.2008.11.911. [DOI] [PubMed] [Google Scholar]

4.Mebazaa A, Ben Hadid R, Cheikh Rouhou R, Trojjet S, El Euch D, Mokni M, et al. Hidradenitis suppurativa: a disease with male predominance in Tunisia. Acta Dermatovenerol Alp Pannonica Adriat. 2009;18(4):165–72. [PubMed] [Google Scholar]

5.Matusiak Ł, Bieniek A, Szepietowski JC. Hidradenitis suppurativa markedly decreases quality of life and professional activity. J Am Acad Dermatol. 2010;62(4):706–8. 708.e1. doi: 10.1016/j.jaad.2009.09.021. [DOI] [PubMed] [Google Scholar]

6.Jemec GB, Heidenheim M, Nielsen NH. The prevalence of hidradenitis suppurativa and its potential precursor lesions. J Am Acad Dermatol. 1996;35(2 Pt 1):191–4. doi: 10.1016/s0190-9622(96)90321-7. [DOI] [PubMed] [Google Scholar]

7.Revuz JE, Canoui-Poitrine F, Wolkenstein P, Viallette C, Gabison G, Pouget F, et al. Prevalence and factors associated with hidradenitis suppurativa: results from two case-control studies. J Am Acad Dermatol. 2008;59(4):596–601. doi: 10.1016/j.jaad.2008.06.020. [DOI] [PubMed] [Google Scholar]

8.Cosmatos I, Matcho A, Weinstein R, Montgomery MO, Stang P. Analysis of patient claims data to determine the prevalence of hidradenitis suppurativa in the United States. J Am Acad Dermatol. 2013;68(3):412–9. doi: 10.1016/j.jaad.2012.07.027. [DOI] [PubMed] [Google Scholar]

9.Canoui-Poitrine F, Le Thuaut A, Revuz JE, Viallette C, Gabison G, Poli F, et al. Identification of three hidradenitis suppurativa phenotypes: latent class analysis of a cross-sectional study. J Invest Dermatol. 2013;133(6):1506–11. doi: 10.1038/jid.2012.472. Epub 2012 Dec 13. [DOI] [PubMed] [Google Scholar]

10.Randhawa HK, Hamilton J, Pope E. Finasteride for the treatment of hidradenitis suppurativa in children and adolescents. JAMA Dermatol. 2013;149(6):732–5. doi: 10.1001/jamadermatol.2013.2874. [DOI] [PubMed] [Google Scholar]

11.Von der Werth JM, Williams HC. The natural history of hidradenitis suppurativa. J Eur Acad Dermatol Venereol. 2000;14(5):389–92. doi: 10.1046/j.1468-3083.2000.00087.x. [DOI] [PubMed] [Google Scholar]

12.Al-Ali FM, Ratnamala U, Mehta TY, Naveed M, Al-Ali MT, Al-Khaja N, et al. Hidradenitis suppurativa (or acne inversa) with autosomal dominant inheritance is not linked to chromosome 1p21.1–1q25.3 region. Exp Dermatol. 2010;19(9):851–3. doi: 10.1111/j.1600-0625.2010.01088.x. [DOI] [PubMed] [Google Scholar]

13.Pink AE, Simpson MA, Desai N, Trembath RC, Barker JN. γ-Secretase mutations in hidradenitis suppurativa: new insights into disease pathogenesis. J Invest Dermatol. 2013;133(3):601–7. doi: 10.1038/jid.2012.372. Epub 2012 Oct 25. [DOI] [PubMed] [Google Scholar]

14.Sartorius K, Emtestam L, Jemec GB, Lapins J. Objective scoring of hidradenitis suppurativa reflecting the role of tobacco smoking and obesity. Br J Dermatol. 2009;161(4):831–9. doi: 10.1111/j.1365-2133.2009.09198.x. Epub 2009 Apr 29. [DOI] [PubMed] [Google Scholar]

15.Vazquez BG, Alikhan A, Weaver AL, Wetter DA, Davis MD. Incidence of hidradenitis suppurativa and associated factors: a population-based study of Olmsted County, Minnesota. J Invest Dermatol. 2013;133(1):97–103. doi: 10.1038/jid.2012.255. Epub 2012 Aug 30. [DOI] [PMC free article] [PubMed] [Google Scholar]

16.Van der Zee HH, Laman JD, Boer J, Prens EP. Hidradenitis suppurativa: viewpoint on clinical phenotyping, pathogenesis and novel treatments. Exp Dermatol. 2012;21(10):735–9. doi: 10.1111/j.1600-0625.2012.01552.x. Epub 2012 Aug 7. [DOI] [PubMed] [Google Scholar]

17.Wiseman MC. Hidradenitis suppurativa: a review. Dermatol Ther. 2004;17(1):50–4. doi: 10.1111/j.1396-0296.2004.04007.x. [DOI] [PubMed] [Google Scholar]

18.Dufresne RG, Jr, Ratz JL, Bergfeld WF, Roenigk RK. Squamous cell carcinoma arising from the follicular occlusion triad. J Am Acad Dermatol. 1996;35(3 Pt 1):475–7. doi: 10.1016/s0190-9622(96)90632-5. [DOI] [PubMed] [Google Scholar]

19.Tennant F, Jr, Bergeron JR, Stone OJ, Mullins JF. Anemia associated with hidradenitis suppurativa. Arch Dermatol. 1968;98(2):138–40. [PubMed] [Google Scholar]

20.Van der Zee HH, de Winter K, van der Woude CJ, Prens EP. The prevalence of hidradenitis suppurativa in 1093 patients with inflammatory bowel disease. Br J Dermatol. 2014;171(3):673–5. doi: 10.1111/bjd.13002. Epub 2014 Jul 22. [DOI] [PubMed] [Google Scholar]

21.Zouboulis CC, Desai N, Emtestam L, Hunger RE, Ioannides D, Juhász I, et al. European S1 guideline for the treatment of hidradenitis suppurativa/acne inversa. J Eur Acad Dermatol Venereol. 2015;29(4):619–44. doi: 10.1111/jdv.12966. Epub 2015 Jan 30. [DOI] [PubMed] [Google Scholar]

22.Alhusayen R, Shear NH. Pharmacologic interventions for hidradenitis suppurativa: what does the evidence say? Am J Clin Dermatol. 2012;13(5):283–91. doi: 10.2165/11631880-000000000-00000. [DOI] [PubMed] [Google Scholar]

23.Danby FW, Margesson LJ. Hidradenitis suppurativa. Dermatol Clin. 2010;28(4):779–93. doi: 10.1016/j.det.2010.07.003. [DOI] [PubMed] [Google Scholar]

24.Ingram JR, Woo PN, Chua SL, Ormerod AD, Desai N, Kai AC, et al. Interventions for hidradenitis suppurativa. Cochrane Database Syst Rev. 2015;10:CD010081. doi: 10.1002/14651858.CD010081.pub2. [DOI] [PMC free article] [PubMed] [Google Scholar]

25.Boer J, Jemec GB. Resorcinol peels as a possible self-treatment of painful nodules in hidradenitis suppurativa. Clin Exp Dermatol. 2010;35(1):36–40. doi: 10.1111/j.1365-2230.2009.03377.x. Epub 2009 Jun 22. [DOI] [PubMed] [Google Scholar]